Plant ID: NPO26788
Plant Latin Name: Sophora viciifolia
Taxonomy Genus: Sophora
Taxonomy Family: Fabaceae
NCBI TaxonomyDB:
1196212
Plant-of-the-World-Online:
n.a.
China
FFAR1; FFAR4; | |
PPARA; | |
ALOX15; TNKS; TNKS2; | |
PTGS2; | |
KDM4E; | |
FABP3; FABP4; LMNA; FABP5; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | TNKS | Tankyrase-1 | O95271 | CHEMBL6164 |
Enzyme_unclassified | TNKS2 | Tankyrase-2 | Q9H2K2 | CHEMBL6154 |
Lysine demethylase | KDM4E | Lysine-specific demethylase 4D-like | B2RXH2 | CHEMBL1293226 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Oxidoreductase | PTGS2 | Cyclooxygenase-2 | P35354 | CHEMBL230 |
Small molecule receptor (family A GPCR) | FFAR1 | Free fatty acid receptor 1 | O14842 | CHEMBL4422 |
Small molecule receptor (family A GPCR) | FFAR4 | G-protein coupled receptor 120 | Q5NUL3 | CHEMBL5339 |
Unclassified | FABP3 | Fatty acid binding protein muscle | P05413 | CHEMBL3344 |
Unclassified | FABP4 | Fatty acid binding protein adipocyte | P15090 | CHEMBL2083 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0005504; fatty acid binding | 4.088E-09 | 8.902E-05 | FABP3, FABP4, FABP5, FFAR4 |
BP | GO:0008152; metabolic process | GO:0019433; triglyceride catabolic process | 8.625E-07 | 1.501E-03 | FABP3, FABP4, FABP5 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 6.647E-07 | 1.501E-03 | CYP19A1, CYP1A1, CYP1B1 |
MF | GO:0003824; catalytic activity | GO:0050473; arachidonate 15-lipoxygenase activity | 1.688E-06 | 1.934E-03 | ALOX15, PTGS2 |
MF | GO:0005488; binding | GO:0020037; heme binding | 2.373E-06 | 2.461E-03 | CYP19A1, CYP1A1, CYP1B1, PTGS2 |
BP | GO:0008152; metabolic process | GO:0070213; protein auto-ADP-ribosylation | 3.374E-06 | 3.194E-03 | TNKS, TNKS2 |
BP | GO:0009987; cellular process | GO:0071248; cellular response to metal ion | 4.230E-06 | 3.684E-03 | ALOX15, CYP1A1, FABP4, PTGS2 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 5.272E-06 | 3.958E-03 | CYP19A1, CYP1A1, CYP1B1 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 5.764E-06 | 4.184E-03 | ALOX15, CYP19A1, CYP1A1, CYP1B1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09152 Endocrine system | hsa04913 | Ovarian steroidogenesis | 4.622E-08 | 1.479E-06 | CYP1A1, CYP1B1, PTGS2, CYP19A1 |
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 1.721E-07 | 2.753E-06 | FABP3, FABP4, FABP5, PPARA |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 1.027E-05 | 1.096E-04 | CYP1A1, CYP1B1, CYP19A1 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 2.917E-05 | 2.334E-04 | CYP1A1, CYP1B1, PTGS2 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 4.028E-04 | 2.578E-03 | CYP1A1, CYP1B1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04923 | Regulation of lipolysis in adipocytes | 7.898E-04 | 4.212E-03 | FABP4, PTGS2 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 9.673E-04 | 4.422E-03 | ALOX15, PTGS2 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.338E-03 | 5.352E-03 | CYP1A1, CYP1B1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Bladder cancer | C67 | CYP19A1; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Ankylosing spondylitis | M08.1, M45 | PTGS2; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Osteoarthritis | M15-M19, M47 | PTGS2; |
C00-D49: Neoplasms | Advanced breast cancer | C50 | CYP19A1; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | PTGS2; |
K00-K95: Diseases of the digestive system | Inflammatory bowel disease | K50, K51 | PTGS2; |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified | Chronic pain | R52.1-R52.2, G89 | PTGS2; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Knee osteoarthritis | M15-M19, M47 | PTGS2; |
C00-D49: Neoplasms | Pancreatic cancer | C25 | PTGS2; |
N00-N99: Diseases of the genitourinary system | Prostate disease | N42.9 | CYP19A1; |
K00-K95: Diseases of the digestive system | Colon polyps | K63.5 | PTGS2; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Hyperthermia | T68 | PTGS2; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Arthritis | M00-M25 | PTGS2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Inflammation | E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89 | PTGS2; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Gout | M10 | PTGS2; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Moderate to severe rheumatoid arthritis | M05-M06 | PTGS2; |
G00-G99: Diseases of the nervous system G00-G99 | Pain | G64, G90.0, R52, G89 | PTGS2; |
J00-J99: Diseases of the respiratory system | Asthma | J45 | PTGS2; |
C00-D49: Neoplasms | Cancer | C00-C96 | PTGS2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | FFAR1; |
G00-G99: Diseases of the nervous system G00-G99 | Neuropathic pain | G64, G90.0 | PTGS2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Non-insulin dependent diabetes | E11.9 | FFAR1; |
C00-D49: Neoplasms | Non-small cell lung cancer | C33-C34 | PTGS2; |
C00-D49: Neoplasms | Hormonally-responsive breast cancer | C50 | CYP19A1; |
NA: NA | Joint and muscular pain | NA | PTGS2; |
N00-N99: Diseases of the genitourinary system | Dysmenorrhea | N94.4-N94.6 | PTGS2; |
NA: NA | Rheumatold arthritis | NA | PTGS2; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | PTGS2; |
N00-N99: Diseases of the genitourinary system | Endometriosis | N80 | PTGS2; CYP19A1; |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | PTGS2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | PTGS2; FFAR1; |
C00-D49: Neoplasms | Breast cancer | C50 | CYP19A1; |